India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Traditional approaches to benchmarking brand performance have struggled to keep pace with industry dynamics. While individual ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

and to establish if there was broad uniformity in how market access was defined and developed. There were 104 responders, comprised of 50% from pharma, 41% from agencies and the remainder from ...

As blockchain expands its reach across different industries, Gunjan Bhardwaj examines some of its practical applications in the pharma industry. Blockchain is quickly increasing in interest and ...

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inozyme Pharma (INZY – Research Report) and ...

India ranked 11th in global pharmaceutical exports in 2023, contributing 3%, while regulators have intensified quality checks, inspected 905 units, and taken 694 enforcement actions since December ...

Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Good morning, ladies and gentlemen, and thank you for standing by.

Biosimilars can not only reduce patients' financial burdens, but also encourage more people to go for early diagnosis and ...